Study shows high efficacy rate for fecal transplants

04/13/2012 | Medscape (free registration)

Fecal transplants resolved recurrent Clostridium difficile infection in more than 90% of patients, according to a report in the American Journal of Gastroenterology. Montefiore Medical Center researchers said the study included long-term follow-up with patients who had followed an average of five unsuccessful courses of traditional treatments without success before having fecal transplantation. "FMT is a rational, durable, safe, and acceptable treatment option for patients with recurrent C. difficile infection," Dr. Lawrence J. Brandt and colleagues wrote.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT